Clean Yield Group Sells 225 Shares of CME Group Inc. (NASDAQ:CME)

Clean Yield Group decreased its stake in CME Group Inc. (NASDAQ:CME) by 51.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 216 shares of the financial services provider’s stock after selling 225 shares during the period. Clean Yield Group’s holdings in CME Group were worth $48,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the stock. Alpha Cubed Investments LLC boosted its position in shares of CME Group by 4.6% in the third quarter. Alpha Cubed Investments LLC now owns 176,629 shares of the financial services provider’s stock valued at $38,973,000 after acquiring an additional 7,784 shares during the period. Cohen Investment Advisors LLC acquired a new stake in shares of CME Group during the 3rd quarter worth $369,000. Miracle Mile Advisors LLC increased its position in shares of CME Group by 18.9% in the third quarter. Miracle Mile Advisors LLC now owns 3,837 shares of the financial services provider’s stock worth $847,000 after purchasing an additional 609 shares during the period. GAMMA Investing LLC raised its stake in CME Group by 27.1% in the third quarter. GAMMA Investing LLC now owns 4,131 shares of the financial services provider’s stock valued at $912,000 after purchasing an additional 881 shares in the last quarter. Finally, Handelsbanken Fonder AB lifted its position in CME Group by 0.9% during the third quarter. Handelsbanken Fonder AB now owns 126,636 shares of the financial services provider’s stock worth $27,942,000 after purchasing an additional 1,083 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analysts Set New Price Targets

Several research firms have commented on CME. Royal Bank of Canada reissued a “sector perform” rating and issued a $235.00 target price on shares of CME Group in a report on Thursday, October 3rd. The Goldman Sachs Group increased their target price on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research report on Thursday, October 3rd. Bank of America boosted their price target on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a report on Thursday, October 3rd. Barclays increased their price objective on CME Group from $209.00 to $219.00 and gave the company an “equal weight” rating in a report on Monday. Finally, JPMorgan Chase & Co. boosted their target price on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $217.71.

Insider Buying and Selling at CME Group

In other news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

CME Group Stock Up 0.4 %

Shares of CME Group stock traded up $0.87 during trading hours on Tuesday, reaching $222.60. The company’s stock had a trading volume of 119,172 shares, compared to its average volume of 1,955,572. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. The stock’s fifty day simple moving average is $212.17 and its two-hundred day simple moving average is $207.64. The company has a market capitalization of $80.15 billion, a P/E ratio of 25.23, a P/E/G ratio of 8.74 and a beta of 0.55. CME Group Inc. has a one year low of $190.70 and a one year high of $226.78.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, beating the consensus estimate of $2.53 by $0.03. The business had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same quarter last year, the firm earned $2.30 EPS. On average, research analysts forecast that CME Group Inc. will post 9.94 earnings per share for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were issued a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.07%. CME Group’s dividend payout ratio (DPR) is currently 52.33%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.